Zhejiang DiAn Diagnostics Co (300244) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.068x

Based on the latest financial reports, Zhejiang DiAn Diagnostics Co (300244) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥594.17 Million ≈ $86.95 Million USD) by net assets (CN¥8.67 Billion ≈ $1.27 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Zhejiang DiAn Diagnostics Co to measure how many days the company can operate on defensive assets alone.

Zhejiang DiAn Diagnostics Co - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Zhejiang DiAn Diagnostics Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang DiAn Diagnostics Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang DiAn Diagnostics Co ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CBIZ Inc NYSE:CBZ	-0.013x
Pebblebrook Hotel Trust NYSE:PEB	0.033x
Inox Wind Limited NSE:INOXWIND	-0.058x
Henan Lingrui Pharmaceutical Co Ltd SHG:600285	0.038x
Grand City Properties SA F:GYC	0.012x
PHARVARIS N.V. EO -12 F:9EN	-0.140x
Jubilant Pharmova Limited NSE:JUBLPHARMA	0.056x
Parade Technologies Ltd TWO:4966	0.039x

Annual Cash Flow Conversion Efficiency for Zhejiang DiAn Diagnostics Co (2008–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang DiAn Diagnostics Co from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang DiAn Diagnostics Co (300244) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.60 Billion ≈ $1.26 Billion	CN¥2.03 Billion ≈ $296.81 Million	0.236x	+71.17%
2024-12-31	CN¥8.77 Billion ≈ $1.28 Billion	CN¥1.21 Billion ≈ $176.68 Million	0.138x	-29.01%
2023-12-31	CN¥9.90 Billion ≈ $1.45 Billion	CN¥1.92 Billion ≈ $281.15 Million	0.194x	+12.44%
2022-12-31	CN¥9.50 Billion ≈ $1.39 Billion	CN¥1.64 Billion ≈ $239.89 Million	0.173x	-2.13%
2021-12-31	CN¥7.48 Billion ≈ $1.09 Billion	CN¥1.32 Billion ≈ $192.85 Million	0.176x	-31.31%
2020-12-31	CN¥6.03 Billion ≈ $882.20 Million	CN¥1.55 Billion ≈ $226.41 Million	0.257x	+172.91%
2019-12-31	CN¥5.14 Billion ≈ $751.88 Million	CN¥483.19 Million ≈ $70.71 Million	0.094x	+18.49%
2018-12-31	CN¥4.70 Billion ≈ $688.18 Million	CN¥373.24 Million ≈ $54.62 Million	0.079x	+507.28%
2017-12-31	CN¥2.95 Billion ≈ $431.21 Million	CN¥38.51 Million ≈ $5.64 Million	0.013x	-74.84%
2016-12-31	CN¥2.55 Billion ≈ $372.55 Million	CN¥132.25 Million ≈ $19.35 Million	0.052x	-58.11%
2015-12-31	CN¥1.06 Billion ≈ $154.94 Million	CN¥131.29 Million ≈ $19.21 Million	0.124x	-26.22%
2014-12-31	CN¥701.84 Million ≈ $102.70 Million	CN¥117.95 Million ≈ $17.26 Million	0.168x	+31.39%
2013-12-31	CN¥589.81 Million ≈ $86.31 Million	CN¥75.44 Million ≈ $11.04 Million	0.128x	+162.88%
2012-12-31	CN¥527.32 Million ≈ $77.16 Million	CN¥25.66 Million ≈ $3.75 Million	0.049x	+14.88%
2011-12-31	CN¥477.04 Million ≈ $69.81 Million	CN¥20.20 Million ≈ $2.96 Million	0.042x	-83.57%
2010-12-31	CN¥159.92 Million ≈ $23.40 Million	CN¥41.23 Million ≈ $6.03 Million	0.258x	+601.12%
2009-12-31	CN¥110.32 Million ≈ $16.14 Million	CN¥4.06 Million ≈ $593.57K	0.037x	+127.90%
2008-12-31	CN¥27.86 Million ≈ $4.08 Million	CN¥-3.67 Million ≈ $-537.24K	-0.132x	--

About Zhejiang DiAn Diagnostics Co

SHE:300244 China Diagnostics & Research

Market Cap

$1.67 Billion

CN¥11.40 Billion CNY

Market Cap Rank

#6944 Global

#1561 in China

Share Price

CN¥18.24

Change (1 day)

+0.39%

52-Week Range

CN¥13.59 - CN¥29.50

All Time High

CN¥46.17